Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $222.61 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $64.15 | 5 | $0 (2020) |
| Novo Nordisk Inc | $54.82 | 4 | $0 (2019) |
| Stryker Corporation | $42.66 | 1 | $0 (2017) |
| DUSA Pharmaceuticals, Inc. | $21.35 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $14.34 | 1 | $0 (2021) |
| Lilly USA, LLC | $12.89 | 1 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $12.40 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $14.34 | 1 | AstraZeneca Pharmaceuticals LP ($14.34) |
| 2020 | $12.14 | 1 | GlaxoSmithKline, LLC. ($12.14) |
| 2019 | $132.12 | 10 | Novo Nordisk Inc ($54.82) |
| 2018 | $21.35 | 1 | DUSA Pharmaceuticals, Inc. ($21.35) |
| 2017 | $42.66 | 1 | Stryker Corporation ($42.66) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, FLUARIX QUADRIVALENT | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: VACCINES | ||||||
| 12/05/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Diabetes | ||||||
| 12/05/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Diabetes | ||||||
| 12/02/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, FLUARIX | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: VACCINES | ||||||
| 11/07/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Diabetes | ||||||
| 10/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Diabetes | ||||||
| 10/03/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| Category: Cardiovascular | ||||||
| 09/18/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, FLUARIX | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: VACCINES | ||||||
| 06/20/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: VACCINES | ||||||
| 05/02/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: VACCINES | ||||||
| 04/15/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 06/28/2018 | DUSA Pharmaceuticals, Inc. | Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug), BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Dermatology | ||||||
| 07/14/2017 | Stryker Corporation | 1588 HD 3 Chip Camera (Device) | Food and Beverage | Cash or cash equivalent | $42.66 | General |
| Category: Visualization | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 13 | 13 | $3,209 | $1,458 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,209 | $1,458 | 45.4% |
About Dr. Ralph Brooks, M.D
Dr. Ralph Brooks, M.D is a Dermatology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467565762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Brooks, M.D has received a total of $222.61 in payments from pharmaceutical and medical device companies, with $14.34 received in 2021. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($222.61).
As a Medicare-enrolled provider, Brooks has provided services to 13 Medicare beneficiaries, totaling 13 services with total Medicare billing of $1,458. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Fort Worth, TX
- Active Since 08/17/2006
- Last Updated 09/30/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1467565762
Products in Payments
- SHINGRIX (Biological) $64.15
- Ozempic (Drug) $54.82
- 1588 HD 3 Chip Camera (Device) $42.66
- Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $21.35
- LOKELMA (Drug) $14.34
- TRULICITY (Drug) $12.89
- Livalo (Drug) $12.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Worth
Dr. Patrick Keehan, D.o, D.O
Dermatology — Payments: $761,024
Dr. Ronald Plott, M.d, M.D
Dermatology — Payments: $467,637
William Cothern, Do, DO
Dermatology — Payments: $41,403
Stephen Weis, Do, DO
Dermatology — Payments: $32,162
Kathryn Durham, Md, MD
Dermatology — Payments: $28,437
Mrs. Betty Rajan, M.d, M.D
Dermatology — Payments: $25,857